1q21.1 deletion syndrome
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| 1q21.1 deletion syndrome | |
|---|---|
| File:Relation 1q21 1.jpg | |
| Synonyms | 1q21.1 microdeletion syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Developmental delay, intellectual disability, congenital heart defects, schizophrenia, autism spectrum disorder |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing, chromosomal microarray analysis |
| Differential diagnosis | 1q21.1 duplication syndrome, other chromosomal abnormalities |
| Prevention | |
| Treatment | Supportive care, special education, therapy |
| Medication | |
| Prognosis | Variable |
| Frequency | 1 in 5,000 to 1 in 10,000 |
| Deaths | |
1q21.1 deletion syndrome is a rare genetic disorder caused by a deletion of a small segment of chromosome 1. This deletion occurs at the q21.1 region, which is located on the long arm of the chromosome. The syndrome is associated with a variety of clinical features, which can vary widely among affected individuals.
Genetic Basis[edit]
The 1q21.1 deletion involves the loss of a segment of DNA that contains several genes. The size of the deletion can vary, but it typically spans approximately 1.35 megabases. This region includes several important genes, such as GJA5, CHD1L, and BCL9. The deletion can occur de novo or be inherited from a parent who carries the deletion but may not show any symptoms.
Clinical Features[edit]
Individuals with 1q21.1 deletion syndrome may exhibit a range of symptoms, including:
- Developmental delay
- Intellectual disability
- Autism spectrum disorder
- Congenital heart defects
- Microcephaly
- Seizures
The severity of these symptoms can vary significantly, even among members of the same family.
Diagnosis[edit]
Diagnosis of 1q21.1 deletion syndrome is typically made using genetic testing methods such as chromosomal microarray analysis or fluorescence in situ hybridization (FISH). These tests can identify the presence of the deletion and help in understanding the genetic basis of the individual's symptoms.
Management[edit]
There is no cure for 1q21.1 deletion syndrome, and treatment is focused on managing the symptoms. This may include:
- Speech therapy and occupational therapy for developmental delays
- Special education services
- Medications to control seizures
- Surgical interventions for congenital heart defects
